1.The immunohistochemical study of the macrophages and natural killer cells in hepatocellular carcinoma tissues
Gang CHEN ; Dianzhong LUO ; Zhenbo FENG ; Fang GUO ; Ping LI
Journal of Medical Postgraduates 2005;18(10):905-910
Objective:To investigate the number and distribution of macrophages (Mφ) and natural killer(NK) cells in hepatocellular carcinoma (HCC), paraneoplastic,cirrhosis and normal liver tissues and their relationship with the prognosis of HCC patients. Methods:Surgical specimens from 60 cases of HCC, 62 cases of cirrhosis and 23 cases of normal liver tissues were investigated by immunohistochemical staining of CD68 and CD57 with a streptavidin-horseradish peroxidase detective system.The correlation of the number of Mφ and NK cells in different tissues with the clinical tumor parameters was also studied. Results:①The order of the number of Mφ from the highest to the lowest was:paraneoplastic,cirrhosis, normal, HCC(P<0.05);and the number of NK cells from the highest to the lowest was:HCC, paraneoplastic, normal, cirrhosis(P<0.05).②The number of Mφ decreased successively with the decrease of the HCC differentiation(P<0.05);There was no relationship between the number of NK cells in HCC and histological grade. ③There was no relationship between the number of Mφ in HCC and clinical TNM stage ;The number of NK cells in HCC had degressive tendency with the clinical TNM stage(P<0.05). ④The number of Mφ and NK cells in HCC in the cases with metastasis in 15 months was significantly lower than that without metastasis(P<0.05, 0.01).⑤There was a linear positive correlation between the number of Mφ and NK cells in HCC (r=0.344, P<0.05). Conclusion:The number of Mφ and NK cells in HCC in the cases with metastasis is significantly lower than that without metastasis;The number of Mφ has a close correlation with the HCC differentiation, and positive correlation with the number of NK cells;The number of Mφ and NK cells might be important markers to estimate the immune status and useful factors to predict the prognosis of HCC patients.
2.Observations of the therapeutic effects and side effects of 6-mercaptopurine on refractory childhood nephrotic syndrome
Zhengkun XIA ; Guangling LIU ; Yuanfu GAO ; Yuanfeng FU ; Lianfeng ZHANG ; Zhongmin FAN ; Jie FU
Journal of Medical Postgraduates 2002;15(6):510-513
Objectives: The aim of the study was to evaluate the therapeutic effects of 6-mercaptopurine in the treatment of refractory childhood nephrotic syndrome (NS). Methods: According to the varieties of NS, 6-mercaptopurine (2 mg/kg body weight daily) combined with corticosteroid or 6-mercaptopurine (2 mg/kg body weight daily) alone after tapering of steroids were given to 28 consecutive children with primary NS in our hospital. Results: One month after the use of 6-mercaptopurine, proteinuria was decreased. The duration of improvement was 9~28 days, with mean duration of 17 days. Over-all effective rate was 85.7%. Among different varieties of NS, the best therapeutic effect was noted in steroid-dependent children; the better therapeutic effect in steroid-resistant children; and good therapeutic effect in frequently relapsing children. The effective rates were 100%, 84.6%, 81.8% respectively. All the pathological varieties of 28 children were confirmed by renal biopsy. The better therapeutic effects were noted in slight mesangial proliferative glomerulonephritis (MsPGN) and minimal change nephrotic syndrome (MCNS). The less therapeutic effect was noted in membranoproliferative glomerulonephritis (MPGN). Their therapeutic effective rates were 92.9%, 80%, 66.7% respectively. Unfortunately, drug-induced aplastic anemia was seen in 2 cases. Slight gastrointestinal reactions were present in 6 cases. There were no side reaction on the gonad. Conclusions: The great difference in the therapeutic effects is related to the different pathologic varieties of NS. With regard to the treatment of refractory NS in children, the pathological varieties should be confirmed by renal biopsy as soon as possible. Based on the renal biopsy, 6-mercaptopurine can be considered in the treatment of MsPGN and MCNS. As a result, relapses could be reduced; the duration of remission could be prolonged, and the side reactions from steroid treatment could be avoided. The use of 6-mercaptopurine for the treatment of refractory NS is one of the effective therapy.
3.Expression of epidermal growth factor receptor and cell proliferative protein in thymic carcinoma and type-B3 thymoma
Journal of Medical Postgraduates 2003;0(10):-
Objective:To investigate the expression of epidermal growth factor receptor(EGFR),survivin,P53 protein and proliferating cell nuclear antigen(PCNA) in thymic carcinoma and type-B3 thymoma. Methods:The clinicopathological changes of thymic carcinoma in 9 cases and of type-B3 thymoma(well differentiated thymic carcinoma) in 21 cases were examined by microscopic observation of immunohistochemical stained EGFR,survivin,P53 protein and PCNA,respectively. Results:Clinically,the median age of the patients with the tumor was 43.5 years old.All the tumors displayed a pattern of infiltration growth.Immunohistochemical staining of the tumors indicated that the expressions of EGFR,survivin,P53 protein and PCNA in thymic carcinoma were 77.8%(7/9),88.8%(8/9),77.8%(7/9) and 100%(9/9),respectively.Meanwhile,in type-B3 thymoma,they were 67.7%(14/21),71.4%(15/21),33.3%(7/21) and 85.7%(18/21),respectively.It was statistically significant that the immunohistochemical phenotypes of the tumor displayed a different reaction for P53 protein. Conclusion:The thymic carcinoma and type-B3 thymoma may possess a complete invasive characteristic,clinically.To discriminate thymic carcinoma and type-B3 thymoma,the expression of P53 protein is a more valuable index than EGFR,survivin or PCNA.
4.Therapeutic effects of ultrasound irradiation microbubble agent in thetreatment of subcutaneous H22 hepatoma of mice
Journal of Medical Postgraduates 2003;0(05):-
Objective:To investigate the therapeutic effects of ultrasound irradiation microbubble agent in the treatment of subcutaneous H22 ascites cells hepatoma of mice.Methods:H22 ascites cells hepatoma models were established by inoculating tumor cells to subcutaneous tissue of mice.Then,mice were randomly allocated into control group,only ultrasound group,ultrasound and microbubble group.The growth of tumor volume was observed and its weight was calculated.The application of pathological examination was adopted after the treatment.The necrosis area percentage(NAP) was calculated.and the apoptotic index was analyzed with terminal deoxynucleotidyl transferase mediated dUTP nick end lebeling(TUNEL) technique.Results:Compared with the control,the growth of tumor in the ultrasound and microbubble group was slow and the inhibitory effect of tumor was obvious;Necrosis area and apoptotic cells number were also increased obviously(P
5.Non-invasive monitoring of acute rejection after heart transplantation
Journal of Medical Postgraduates 2003;0(11):-
Heart transplantation(HT) has been an effective method to treat end-stage heart disease, one main factor affecting the long-term survival rate is acute and/or chronic rejection after HT. Trans internal jugular endomyocardial biopsy(EMB) has been the "gold standard" to judge the rejection after HT, but it is also limited. Electrocardiogram ,echocardiogram, immunological monitoring and imaging monitoring can judge the rejection after HT and induce the EMB.
6.Research progress of correlation between NF-?B and CPB
Journal of Medical Postgraduates 2003;0(11):-
Nuclear factor kappa B(NF-?B) is an important transcription factor in the expression of many inflammatory media. With the recent progress of molecular biological technique, the modulated mechanism of NF-?B in immunity, stress, inflammatory responses, and the differentiation and growth of lymphocyte has been the focus. This review presents the role of NF-?B in ischemia-reperfusion and cardiopulmonary bypass, and the research progression of intervention therapy in inhibition of the activation of NF-?B is also introduced herein after.
7.SARS epidemiology research
Journal of Medical Postgraduates 2003;0(11):-
Severe acute respiratory syndrome(SARS),also called infectious atypical pneumonia,is an emerging infectious disease caused by a novel variant of coronavirus.Its transmission is by droplet spread,requiring close contact.The author primarily review the source of the outbreak and path and model of transmission and epidemiologic characterics.
8.The relationship of insulin resistance and the abnormal state of thrombosis and fibrinolysis
Journal of Medical Postgraduates 2003;0(11):-
Insulin resistance(IR) is a independent risk factor of ichemic angiopathy .The abnormal state of thrombosis and fibrinolysis is a critical pathology component of IR,and play a vital role in initiating and developing cardiovasculer disease. Under IR state, the,inhancement of plasminogen-activator inhibitior-1(PAI-1)synthesis by adipose tissue and the reduced generation of nitric oxide with endothelial dysfunction contribute to the hypo-fibrinolytic/pro-thrombotic state and promote atherosclerotic. Accompanied with IR developing, when B cell function can't keep normal glycemia, the advanced glycosylation end products(AGEs) are increased as a result of hyperglycemia. AGEs can aggravate endothelial injury and accelerate the course of atherosclerotic. Fully comprehending the pathogenesis of thrombosis and fibrinolysis in IR and taking therapy for the pathology have clinical significance.
9.A novel drug coated stent and coronary restenosis
Journal of Medical Postgraduates 2003;0(11):-
The placement of stent in coronary artery reduces the restenosis rate of percutaneous transluminal coronary angioplasty(PTCA),but the restenosis has perplexed us so far. May be a novel drug coated stent will bring us a new hope in the coming years.
10.Advances on pharmacotherapy for erectile dysfunction
Journal of Medical Postgraduates 2003;0(11):-
It is reported that plenty of men,especially the aged,have been bothering in penile erectile dysfunction(ED).There are series of treatments for ED.Oral erectogenic agents have become the first-line treatment options,including drugs that act on the central and peripheral nervous systems,testosterone,traditional Chinese medicine and so on.Sidenafil,apomorphine and yohimbine are the only three oral therapies currently available for the treatment of this disorder.The second therapy includes intracavernosum injection,transurethral medications,transdermal medications etc.Intracavernosum injection of PGE 1 is an effective approach at the present.With the rapid understanding of erectile physiology and etiology of ED and the introduction of new effective oral agents,the future of pharmacotherapy for ED will extend.In this review,we have highlighted the advances in current treatments and therapeutic approaches in male erectile dysfunction.